-
Information-Publications
-
Transferrin receptor levels and its rare variant are associated with human obesityDetails -
Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitorsDetails -
IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with …Details -
The transcription factor KLF14 attenuates LPS-induced acute lung injury by ameliorating apoptosis of alveolar epithelial cells in miceDetails -
The negative effect of G1958A polymorphism on MTHFD1 protein stability and HCC growthDetails -
Oxoaporphine Pr (III) complex inhibits hepatocellular carcinoma progression and metastasis by disrupting tumor cell–macrophage crosstalkDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
